Iskani rezultati za avtorja

1

Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines od Packer, Milton

Izdano 2018

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
2

Potentiation of Insulin Signaling Contributes to Heart Failure in Type 2 Diabetes: A Hypothesis Supported by Both Mechanistic Studies and Clinical Trials od Packer, Milton

Izdano 2018

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
3

Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrilla... od Packer, Milton

Izdano 2019

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
4

Disease–treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue... od Packer, Milton

Izdano 2019

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
5

Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completio... od Packer, Milton

Izdano 2019

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
6

Methodological and Clinical Heterogeneity and Extraction Errors in Meta‐Analyses of Catheter Ablation for Atrial Fibrillation in Heart Failure od Packer, Milton

Izdano 2019

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
7

Potential Role of Atrial Myopathy in the Pathogenesis of Stroke in Rheumatoid Arthritis and Psoriasis: A Conceptual Framework and Implications for Prophylaxis od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
8

$What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?$

What causes sudden death in patients with chronic heart failure and a reduced ejection fraction? od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
9

Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose C... od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
10

Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
11

$Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care$

Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
12

Characterization, Pathogenesis, and Clinical Implications of Inflammation‐Related Atrial Myopathy as an Important Cause of Atrial Fibrillation od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
13

Mutual Antagonism of Hypoxia-Inducible Factor Isoforms in Cardiac, Vascular, and Renal Disorders od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
14

Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failure od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
15

Molecular, Cellular, and Clinical Evidence That Sodium‐Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure od Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
16

What causes exertional dyspnoea in patients with atrial fibrillation? Implications for catheter ablation in patients with heart failure od Packer, Milton

Izdano 2021

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
17

$Guideline‐directed medical therapy for heart failure does not exist: a non‐judgmental framework for describing the level of adherence to evidence‐based drug treatments for patients with a reduced ejection fraction$

Guideline‐directed medical therapy for heart failure does not exist: a non‐judgmental framework for describing the level of adherence to evidence‐based drug treatments for patients... od Packer, Milton, Metra, Marco

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
18

Development of autophagy inducers in clinical medicine od Levine, Beth, Packer, Milton, Codogno, Patrice

Izdano 2015

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
19

$Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction$

Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction od Packer, Milton, McMurray, John J.V.

Izdano 2021

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:
20

$Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice$

Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice od Butler, Javed, Zannad, Faiez, Filippatos, Gerasimos, Anker, Stefan D., Packer, Milton

Izdano 2020

Polni tekst Polni tekst Polni tekst
Text

Dodaj v priljubljene

Shranjeno v:

Rezultati - Packer, Milton

Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines od Packer, Milton

Potentiation of Insulin Signaling Contributes to Heart Failure in Type 2 Diabetes: A Hypothesis Supported by Both Mechanistic Studies and Clinical Trials od Packer, Milton

Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrilla... od Packer, Milton

Disease–treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue... od Packer, Milton

Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completio... od Packer, Milton

Methodological and Clinical Heterogeneity and Extraction Errors in Meta‐Analyses of Catheter Ablation for Atrial Fibrillation in Heart Failure od Packer, Milton

Potential Role of Atrial Myopathy in the Pathogenesis of Stroke in Rheumatoid Arthritis and Psoriasis: A Conceptual Framework and Implications for Prophylaxis od Packer, Milton

What causes sudden death in patients with chronic heart failure and a reduced ejection fraction? od Packer, Milton

Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose C... od Packer, Milton

Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs od Packer, Milton

Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care od Packer, Milton

Characterization, Pathogenesis, and Clinical Implications of Inflammation‐Related Atrial Myopathy as an Important Cause of Atrial Fibrillation od Packer, Milton

Mutual Antagonism of Hypoxia-Inducible Factor Isoforms in Cardiac, Vascular, and Renal Disorders od Packer, Milton

Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failure od Packer, Milton

Molecular, Cellular, and Clinical Evidence That Sodium‐Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure od Packer, Milton

What causes exertional dyspnoea in patients with atrial fibrillation? Implications for catheter ablation in patients with heart failure od Packer, Milton

Guideline‐directed medical therapy for heart failure does not exist: a non‐judgmental framework for describing the level of adherence to evidence‐based drug treatments for patients... od Packer, Milton, Metra, Marco

Development of autophagy inducers in clinical medicine od Levine, Beth, Packer, Milton, Codogno, Patrice

Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction od Packer, Milton, McMurray, John J.V.

Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice od Butler, Javed, Zannad, Faiez, Filippatos, Gerasimos, Anker, Stefan D., Packer, Milton

Iskalna orodja: